← Eichor
Study identifier: NCT04685772 Synced from ClinicalTrials.gov · July 29, 2026
● Recruiting

Assessment of the Efficacy of Medrol Dose Pack for Acute Post-Concussive Headaches

Condition: Post-Concussion Syndrome · Headache  ·  Sponsor: Northwell Health

PhaseN/A
Planned participants25
Who can joinAll sexes, 18 Years to no upper limit
Healthy volunteersNo

About this study

This novel pilot project will assess the effectiveness of corticosteroids in treatment of acute post-concussion headache. The investigators hypothesize that the use of corticosteroids will cause significant headache reduction in frequency and/or intensity than individuals who undergo the current standard of care. Additionally, the investigators hypothesize that corticosteroid use will lead to a reduction in other somatic symptoms including vestibular symptoms, leading to quicker return to school, work, and/or ability to play sports.

This description comes directly from the study's public registry record.

Talk to the study team

Jamie Ullman, MD  ·  (516) 562 4300  ·  Jullman1@northwell.edu

Betsy Moclair, RN, CCRC  ·  (516) 253-7753  ·  bmoclair@northwell.edu

Always discuss trial participation with your own doctor first.

Locations (1)

Northwell Health - North Shore University HospitalManhasset, New York, United StatesRecruiting

Follow this study

Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.

We email about this public record only. Unsubscribe anytime with one click. Never medical advice.

Is this your study? This page was generated automatically from the public registry record. Sponsors can claim it — free — to add branding and verified contact routing. Claim this page →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.

Source record: clinicaltrials.gov/study/NCT04685772